Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
CONCLUSION: Failure to achieve CR with induction therapy, and age >65 years are associated with poor outcomes in MS. Allogeneic stem-cell transplant in first remission appears to be the most effective modality for achieving long-term remissions.
PMID: 28574302 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Epidemiology | Hematology | Leukemia | Sarcomas | Skin | Stem Cell Therapy | Stem Cells | Transplants